Evidence map›Paper›PMID 30613973›Full record

ArticleJournal of cellular physiology2019

Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.

Da-Chuang Liu, Lin-Lin Song, Qing Liang, Lin Hao, Zhi-Guo Zhang, Cong-Hui Han

RetractedAbstract readRetracted Publication
In one paragraph

Article in Journal of cellular physiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Da-Chuang LiuDepartment of Urology, Xuzhou Central Hospital, Xuzhou, P. R. China.
Lin-Lin SongDepartment of Respiratory, Xuzhou Central Hospital, Xuzhou, P. R. China.
Qing LiangDepartment of Urology, Xuzhou Central Hospital, Xuzhou, P. R. China.
Lin HaoDepartment of Urology, Xuzhou Central Hospital, Xuzhou, P. R. China.
Zhi-Guo ZhangDepartment of Urology, Xuzhou Central Hospital, Xuzhou, P. R. China.
Cong-Hui HanDepartment of Urology, Xuzhou Central Hospital, Xuzhou, P. R. China.ORCID 0000-0002-5624-9409
Xuzhou Central Hospital · CNXuzhou Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (PCa) is one of the major cancers affecting males with high mortality around the world. Recent studies have found that some long noncoding RNAs play a critical part in the cellular processes of PCa. In our study, aberrant expressed lymphoid enhancer-binding factor-1 antisense RNA 1 (LEF1-AS1), microRNA-330-5p (miR-330-5p), and lymphoid enhancer-binding factor-1 (LEF1) were screened out from a microarray database, the role of the novel noncoding RNA regulatory circuitry in the initiation and development of PCa was investigated. LEF1-AS1 and LEF1 were highly expressed while miR-330-5p was poorly expressed in PCa. Following that, the PCa PC-3 cell line was adopted for subsequently experiments, in which the expression of LEF1-AS1 and miR-330-5p was subsequently altered by means of exogenous transfection. After that, the effects of up- or downregulation of LEF1-AS1 and miR-330-5p on epithelial-mesenchymal transition (EMT) and the cell ability for proliferation, invasion, migration in vitro, and tumorigenesis and lymph node metastasis (LNM) in vivo were evaluated. RNA crosstalk revealed that LEF1-AS1 bound to miR-330-5p and LEF1 was the target gene of miR-330-5p. Silenced LEF1-AS1 or elevated miR-330-5p exhibited inhibited EMT processes, reduced ability of proliferation, invasion and migration, coupling with decreased tumorigenesis and LNM in nude mice. The key findings of this study collectively propose downregulation of LEF1-AS1 competing with miR-330-5p to inhibit EMT, invasion and migration of PCa by LEF1 repression.

Indexed as

RNA InterferenceRNA, Long NoncodingAgedAged, 80 and overAnimalsGene Expression Regulation, NeoplasticHumansLymphoid Enhancer-Binding Factor 1MaleMiceMice, NudeMicroRNAsMiddle AgedNeoplasms, ExperimentalProstatic NeoplasmsLEF1 protein, humanLymphoid Enhancer-Binding Factor 1MicroRNAsMIRN330 microRNA, humanRNA, Long Noncodingepithelial-mesenchymal transitioninvasionLEF1long noncoding RNA LEF1-AS1microRNA-330-5pmigrationprostate cancer

Identifiers

PMID30613973
PMCPMC13483272
OpenAlexW2910217835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.